Group 1 - The core viewpoint of the article highlights the growth of the insurance industry in Jiangxi Province, with a total original insurance premium income of 81.993 billion yuan from January to July 2025, representing a year-on-year increase of 6.22% [1] - Among different types of insurance, life insurance accounted for the highest share, totaling 46.192 billion yuan, which is 56.34% of the total premium income [1] - The article references a report by Zhiyan Consulting that analyzes the development and investment prospects of the Chinese insurance industry from 2025 to 2031 [1] Group 2 - The listed companies mentioned include Tianmao Group (000627), China Ping An (601318), China Pacific Insurance (601601), China Life (601628), China People’s Insurance (601319), and Xinhua Insurance (601336) [1] - Zhiyan Consulting is recognized as a leading industry consulting firm in China, providing in-depth industry research reports, business plans, feasibility studies, and customized services [1] - The data source for the insurance premium statistics is the National Financial Supervision Administration, organized by Zhiyan Consulting [1]

Core Viewpoint - *ST Tianmao has applied for voluntary delisting from the Shenzhen Stock Exchange, indicating significant operational and financial challenges faced by the company [2][5]. Group 1: Delisting Application - On September 11, 2025, *ST Tianmao announced that the Shenzhen Stock Exchange has accepted its application for voluntary delisting [2]. - The application for delisting was submitted on September 4, 2025, and the company received confirmation of acceptance from the exchange on September 10, 2025 [2]. Group 2: Financial Reporting Issues - On April 29, 2025, *ST Tianmao announced a delay in the release of its 2024 annual report and the 2025 Q1 report, citing the need for further information supplementation [3]. - This delay led to a significant market reaction, with the stock experiencing multiple trading halts due to investor concerns over the company's transparency [3]. Group 3: Financial Performance and Liquidity Risks - The company is facing substantial financial pressure, with a projected loss of between 500 million to 750 million yuan for the year 2024, primarily due to increased reserves at its subsidiary, Guohua Life [4]. - Guohua Life reported a high policy surrender amount of 20.6 billion yuan in 2023, with claims rising to 21.822 billion yuan in the first three quarters of 2024, exacerbating liquidity concerns for *ST Tianmao [4]. Group 4: Business Restructuring - On August 14, 2025, *ST Tianmao announced plans to initiate a voluntary delisting process due to significant uncertainties affecting its business structure [5]. - Following the delisting, the company intends to apply for transfer to the National Equities Exchange and Quotations (NEEQ) for trading in the delisted segment [5].

Group 1 - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% of the company's total shares, amounting to approximately 174 million shares [1] - Jinlongyu's shareholder terminates the share transfer agreement, halting the planned transfer of 5.32% of the company's shares [1] - Doli Technology's subsidiary plans to establish a joint venture in Spain with an investment of approximately 505 million yuan, with a 70% stake held by Doli Technology [1][2] Group 2 - Chongqing Pharmaceutical, a subsidiary of Zhongyao Holdings, has received approval for clinical trials of its drug, Clopidogrel Hydrochloride Tablets [3][4] - Dongyangguang plans to jointly increase capital in a subsidiary to acquire 100% of Qinhuai Data China for 28 billion yuan [5] - Kangzhi Pharmaceutical's controlling shareholder intends to transfer 5.0004% of the company's shares at a price of 5.34 yuan per share, totaling approximately 122 million yuan [6] Group 3 - Huali Co., Ltd. announces two shareholders plan to reduce their stakes by a combined total of up to 3.96% of the company's shares [7] - Fangbang Co., Ltd.'s director plans to reduce his stake by up to 15,000 shares, representing 0.1844% of the total shares [8] - China Pacific Insurance suggests issuing HKD-denominated convertible bonds, with proceeds aimed at supporting its main insurance business and strategic initiatives [9] Group 4 - Microchip Biotech's shareholder plans to reduce its stake by up to 3% of the company's total shares [10] - Hongbai New Materials' controlling shareholder intends to reduce its stake by up to 3% due to funding needs [11] - Zhejiang Rongtai clarifies that its sales in the robotics components sector are minimal and will not significantly impact annual net profit [12] Group 5 - ST Tianmao voluntarily withdraws its application for A-share listing, which has been accepted by the Shenzhen Stock Exchange [13] - Qingxin Environment's shareholder plans to reduce its stake by up to 1% of the company's total shares [14] - Lanjik Technology's two shareholders plan to reduce their stakes by a combined total of up to 2% of the company's shares [15] Group 6 - BYD's executives and core personnel collectively increased their holdings in the company by approximately 52.33 million yuan [16] - Trina Solar's subsidiary signs contracts for the sale of 2.48 GWh of energy storage products, marking a significant overseas order [17] - Chutianlong's shareholder plans to reduce its stake by up to 3% of the company's total shares [18] Group 7 - Zhongjuxin's shareholder plans to reduce its stake by up to 2.5% of the company's total shares due to funding needs [19] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [20] - Shoukai Co., Ltd. reports a signed contract amount of 973 million yuan for August, with cumulative contracts of 13.15 billion yuan for the year [21] Group 8 - Jucheng Co., Ltd.'s shareholder plans to reduce its stake by up to 2.61% of the company's total shares due to personal funding needs [22]

New Stock Issuance - The new stock issued by Haocreat Technology (证券代码: 301668) is priced at 21.00 RMB per share, effective from September 11, 2025[1] - Cash option declaration period for *ST Tianmao (证券代码: 000627) is from September 15 to September 19, 2025[1] - *ST Zitian (证券代码: 300280) will enter the delisting arrangement period starting September 15, 2025[1] Market Alerts - Significant abnormal fluctuations reported for Kaipu Cloud (证券代码: 688228) on September 11, 2025[1] - The latest announcements for various stocks can be accessed through the provided links, indicating ongoing market activity and updates[1] Trading Updates - Multiple stocks including Shanghai Electric (证券代码: 600021) and Tianji Shares (证券代码: 002759) have recent announcements affecting their trading status[1] - The report includes a comprehensive list of stocks with their respective announcements and trading updates, reflecting the dynamic nature of the market[1]

天茂实业集团股份有限公司 证券代码：000627 证券简称：*ST天茂 公告编号：2025-056 公司将在深交所作出公司股票终止上市的决定后刊登终止上市公告。敬请广大投资者注意投资风险。 特此公告。 天茂实业集团股份有限公司董事会 2025 年 9 月 10 日 天茂实业集团股份有限公司（以下简称"天茂集团"或"公司"）拟以股东会决议方式主动撤回A股股票在 深圳证券交易所（以下简称"深交所"）的上市交易，并在股票终止上市后申请转入全国中小企业股份转 让系统有限责任公司代为管理的退市板块转让（以下简称"本次终止上市"）。本次终止上市事项已于 2025年8月25日经公司2025年第一次临时股东会审议通过。 根据《深交所股票上市规则》的相关要求，公司已于2025年9月4日向深交所提交了本次终止上市申请。 2025年9月10日，公司收到深交所《关于同意受理天茂实业集团股份有限公司股票终止上市申请的函》 （公司部函〔2025〕第281号），深交所正式受理公司股票终止上市申请。 根据《深交所股票上市规则》的相关规定，深交所在受理公司申请后的十五个交易日内，深交所上市委 员会形成审议意见。深交所将根据上市委员会的审议意见 ...

Group 1 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of 100% equity in Qinhuai Data China, with a total investment of 75 billion yuan [2] - Baiyin Nonferrous Metals is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [3] - Beida Pharmaceutical intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [5] Group 2 - ST Tianmao plans to withdraw its A-share listing and transfer to the National SME Share Transfer System after delisting [5] - Goldwind Technology has approved an investment agreement for a 3GW wind-hydrogen-ammonia integration project in Inner Mongolia, with a total investment of approximately 189.2 billion yuan [6] - Langzi Co. has signed an agreement to acquire 67.5% of Chongqing Milan Baiyu Shiguang Medical Beauty Hospital for 92.475 million yuan [7] Group 3 - Dongfang Guoxin is establishing a joint venture with Beijing Shunyi Financial Holdings to focus on computing power infrastructure and services, with a registered capital of 300 million yuan [8] - ST Hezhong's chairman is under bail pending trial, but the company's operations remain unaffected [9] - Kangzhi Pharmaceutical's major shareholder is transferring 22.758 million shares at a price of 5.34 yuan per share, totaling 122 million yuan [9] Group 4 - Shenzhen Airport reported a passenger throughput of 5.807 million in August, a year-on-year increase of 4.07% [10] - Lin Yang Energy won a bid for a project with a total amount of approximately 244.08 million yuan [11] - Fullpower New Materials received a government subsidy of 20 million yuan, which is expected to positively impact its 2025 profits [14] Group 5 - BYD executives and core personnel collectively increased their holdings by 48.82 million shares, totaling 52.3278 million yuan [16] - Hualing Steel's major shareholder increased its stake by 6.90862 million shares, representing a 1% increase in ownership [16]

Group 1 - Tianpu Co., Ltd. experienced a significant stock price increase of 185.29% from August 22 to September 10, leading to a halt for further investigation due to abnormal trading [4] - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Qingshan Paper Industry confirmed that its production and operational activities are normal, with no significant changes in daily operations [6] Group 2 - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer by its controlling shareholder [7] - ST Jinke will implement a capital reserve transfer to increase share capital, resulting in a one-day stock suspension [8] - ST Haofeng's stock will resume trading on September 11 after a share transfer agreement was signed, making Zhixin Network the controlling shareholder [9] Group 3 - Fushun Special Steel's stock will be suspended for one day due to a tender offer for shares by Ningbo Meishan Free Trade Port Zone Jincheng Shazhou Equity Investment Co., Ltd. [10] - Fuliwang's subsidiary plans to invest 500 million yuan in a high-end wire material research and production project [11] - ST Tianmao's application for voluntary delisting has been accepted by the Shenzhen Stock Exchange [12] Group 4 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of Qinhuai Data China [13] - Betta Pharmaceuticals intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Longzi Co., Ltd. plans to acquire a 67.5% stake in Chongqing Time for approximately 92.475 million yuan [15] Group 5 - Dongfang Guoxin plans to establish a joint venture for a technology company with Shunyi Jin Kong [16] - ST Lianshi signed a pre-restructuring investment agreement with selected investors [18] - Shaanxi Construction Group won four construction projects worth over 5 billion yuan in August [19] Group 6 - Dema Technology won a smart logistics project with a well-known Latin American e-commerce giant, valued at approximately 290 million yuan [20] - Mongolian Grass Ecology's subsidiary led a consortium to win a 225 million yuan ecological restoration project [21] - Dajin Heavy Industry signed a long-term production agreement for offshore wind power foundations, with a total value of about 1.25 billion yuan [24] Group 7 - Zhendong Medical's controlling shareholder plans to transfer 5% of the company's shares [25] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [26] - BYD's senior management and core personnel collectively increased their holdings by approximately 52.33 million yuan [27] Group 8 - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% [28] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% [30] - Lanke Technology's shareholders plan to reduce their holdings by up to 2% [31]

每经AI快讯，9月10日，*ST天茂（000627）(000627.SZ)公告称，公司拟以股东会决议方式主动撤回A 股股票在深交所的上市交易，并在股票终止上市后申请转入全国中小企业股份转让系统有限责任公司代 为管理的退市板块转让。公司已于2025年9月4日向深交所提交了本次终止上市申请，深交所已于9月10 日正式受理。根据规定，深交所将在受理申请后的十五个交易日内形成审议意见，并作出是否终止公司 股票上市的决定。公司主动终止上市不设退市整理期，股票自深交所公告终止上市决定之日起五个交易 日内摘牌。 ...

Group 1 - The company *ST Tianmao (000627) announced its decision to voluntarily withdraw its A-share listing on the Shenzhen Stock Exchange [1] - The company submitted its application for termination of listing to the Shenzhen Stock Exchange on September 4 [1] - On September 10, the company received a notice from the Shenzhen Stock Exchange confirming the acceptance of its application for termination of listing [1] Group 2 - After the termination of listing, the company plans to apply for transfer to the National Small and Medium Enterprises Share Transfer System for management in the delisting sector [1]

Core Points - *ST Tianmao (000627.SZ) has submitted an application for termination of listing to the Shenzhen Stock Exchange on September 4, 2025 [1] - On September 10, 2025, the company received a letter from the Shenzhen Stock Exchange confirming the acceptance of its application for termination of listing [1] Summary by Category Company Actions - The company has officially applied for termination of its stock listing in accordance with the relevant rules of the Shenzhen Stock Exchange [1] - The application was submitted on September 4, 2025, and was formally accepted by the exchange on September 10, 2025 [1] Regulatory Response - The Shenzhen Stock Exchange has acknowledged the receipt of the termination application through a formal letter [1]